Biogen Stocks Fall As They Tweak Their Research

 

The Biotechnology company Biogen is changing plans for their study on Alzheimer’s based on mid-study findings, making investors less confident. Based on their findings, 510 patients will need to be added to the final stage of the study. Biogen CMO Al Sandrock said, “ We did do a preplanned blinded sample size re-estimation. We did see more variability in the primary endpoint than assumed when we did the original sample size estimation, so we decided to increase the sample size to maintain 90% power. Therefore, we’re going to add 510 patients to the two studies.” With the recent changes and growing concerns for their stockholders, hopefully Biogens study will still pay off.

Follow us on social media for the latest updates in B2B!

Image

Latest

creative career
Crafted Journey How To: Building a Creative Career Across Scripts, Stages, and Sound
June 8, 2026

Creative careers rarely move in a straight line, especially for writers working across stage, screen, audio, books, and independent film. Sustaining that kind of life often means finding opportunities wherever they appear, building a strong network, staying open to different formats, and saying yes to collaborations that can lead somewhere unexpected. The stakes are…

Read More
EMR
EMR Strategy, Consulting, and Career Pivots with MedSys Co-Founder Mark Embry
June 8, 2026

Electronic medical records (EMRs) have moved from a back-office upgrade to a frontline determinant of care quality, clinician burnout, and hospital economics. With U.S. hospitals often spending tens to hundreds of millions—sometimes exceeding $100 million—on EMR implementations, the stakes have never been higher for getting both the technology and the human adoption right. As…

Read More
radiology
Growing Without Compromise: How Vision Radiology Balances Scale, AI, and Clinical Quality
June 4, 2026

Radiology sits at the center of a modern healthcare squeeze: imaging volumes are climbing, hospitals need faster reads, and there simply are not enough radiologists to meet demand the old way. At the same time, remote work and AI are reshaping what a clinical practice can look like. The challenge is no longer whether…

Read More
Radar
Physical Retail’s Next Infrastructure Layer: Item-Level Intelligence with Radar
June 4, 2026

Physical retail is under pressure to become as measurable and responsive as e-commerce. While retailers have spent years optimizing digital channels with real-time data, store teams have often had to make decisions with incomplete inventory visibility and delayed operational signals. That gap matters because stores still account for 80% of U.S. retail sales, making…

Read More